278 related articles for article (PubMed ID: 32209347)
1. Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.
Durrani AF; Atta S; Bhat AK; Mammen A; Dhaliwal D; Kowalski RP; Jhanji V
Am J Ophthalmol; 2020 Jun; 214():119-126. PubMed ID: 32209347
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
Chang VS; Dhaliwal DK; Raju L; Kowalski RP
Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
[TBL] [Abstract][Full Text] [Related]
3. Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery.
Solomon R; Donnenfeld ED; Perry HD; Rubinfeld RS; Ehrenhaus M; Wittpenn JR; Solomon KD; Manche EE; Moshirfar M; Matzkin DC; Mozayeni RM; Maloney RK
Am J Ophthalmol; 2007 Apr; 143(4):629-34. PubMed ID: 17320811
[TBL] [Abstract][Full Text] [Related]
4. Early-onset methicillin-resistant Staphylococcus aureus keratitis and late-onset infectious keratitis in astigmatic keratotomy incision following femtosecond laser-assisted cataract surgery.
Chou TY; Abazari A; Barash A; Shah S; Kaplowitz K
J Cataract Refract Surg; 2015 Aug; 41(8):1772-7. PubMed ID: 26432137
[TBL] [Abstract][Full Text] [Related]
5. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Panda A; Ahuja R; Sastry SS
Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
[TBL] [Abstract][Full Text] [Related]
7. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
Jhanji V; Sharma N; Satpathy G; Titiyal J
J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
[TBL] [Abstract][Full Text] [Related]
8. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.
Khokhar S; Sindhu N; Mirdha BR
Infection; 2000; 28(3):149-52. PubMed ID: 10879638
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
[TBL] [Abstract][Full Text] [Related]
11. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M
Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649
[TBL] [Abstract][Full Text] [Related]
12. Atopic keratoconjunctivitis with corneal ulcer. Case report.
Zemba M; Burcea M; Camburu G
Rom J Ophthalmol; 2016; 60(3):200-206. PubMed ID: 29450349
[No Abstract] [Full Text] [Related]
13. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
[TBL] [Abstract][Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea.
Sotozono C; Inagaki K; Fujita A; Koizumi N; Sano Y; Inatomi T; Kinoshita S
Cornea; 2002 Oct; 21(7 Suppl):S94-101. PubMed ID: 12484707
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
Palioura S; Gibbons A; Miller D; OʼBrien TP; Alfonso EC; Spierer O
Cornea; 2018 Mar; 37(3):326-330. PubMed ID: 29408828
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes.
Major JC; Engelbert M; Flynn HW; Miller D; Smiddy WE; Davis JL
Am J Ophthalmol; 2010 Feb; 149(2):278-283.e1. PubMed ID: 19926069
[TBL] [Abstract][Full Text] [Related]
18. Topical Vancomycin 5% Is More Efficacious Than 2.5% and 1.25% for Reducing Viable Methicillin-Resistant Staphylococcus aureus in Infectious Keratitis.
Romanowski EG; Romanowski JE; Shanks RMQ; Yates KA; Mammen A; Dhaliwal DK; Jhanji V; Kowalski RP
Cornea; 2020 Feb; 39(2):250-253. PubMed ID: 31658169
[TBL] [Abstract][Full Text] [Related]
19. Bilateral methicillin-resistant staphylococcus aureus keratitis in a medical resident following an uneventful bilateral photorefractive keratectomy.
Solomon R; Donnenfeld ED; Perry HD; Biser S
Eye Contact Lens; 2003 Jul; 29(3):187-9. PubMed ID: 12861116
[TBL] [Abstract][Full Text] [Related]
20. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ
Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
